The Recanati/Miller Transplantation Institute at Mount Sinai provides comprehensive, personalized treatment and compassionate care to people with a wide variety of liver/bile duct and pancreatic diseases, including cancers affecting these organs. Our multidisciplinary team of leaders in hepatology, hepatobiliary surgery, surgical oncology, nursing, anesthesiology, critical care, radiology, virology, genetics, pathologists, and transplant immunology come together to evaluate the needs of each patients and to develop an individualized treatment plan. This interdisciplinary approach enables us to provide the best in patient care, using state-of-the-art medical, surgical, and imaging techniques, many of which we pioneered. We emphasize timely treatment to help avoid advanced complications due to liver disease or liver/bile duct cancer.
In addition to our extensive experience in liver transplantation, we are leaders in providing alternative, state-of-the-art surgical treatments such as liver resection for liver/bile duct cancer, in which affected parts of the liver are removed rather than the whole organ. In many cases, we are able to perform liver resections using minimally invasive, laparoscopic techniques which require smaller incisions and can lead to faster recovery times. We provide a full range of other innovative, minimally invasive treatment modalities such as radiofrequency ablation and transarterial chemoembolization as well.
Our patients can be confident they will receive optimal care at our multi-organ transplantation facility. An outstanding feature of our program is the superior continuum of care we offer. Patients are tracked by the same team of providers pre- and post-transplant.